Additionally, pharmacological activation of EP4 results in improved cardiomyocyte contractile parameters and improved cardiac function following ischemic injury (Gu et al., 2016), whereas mice with cardiac‐specific EP4 inactivation exhibit reduced cardiac function following myocardial ischemia (Qian et al., 2008). The gene discussed is PTGER4; the disease is myocardial ischemia.